Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Specific Objectives:
- To determine if individuals who carry a decreased or non-functional variant of OCT1
exhibit differences in the pharmacokinetics of metformin in comparison to individuals
who carry the common allele.
- To determine if individuals who carry the decreased or non-functional variants exhibit
differences in the response to metformin in comparison to individuals who carry the
common allele.